User login
A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on a faculty interview and reviews of selected posters that were presented at a medical conference held February 18-22, 2005, in New Orleans.
•Contents
•Faculty/Faculty Disclosure Statement
To view the supplement, click the image above.
Contents
• Combination Tazarotene and Clindamycin/Benzoyl Peroxide
• Use of Clindamycin 1%/Benzoyl Peroxide 5% Gel Alone and in Combination for Acne Vulgaris
• Patient Preference for Clindamycin/Benzoyl Peroxide Gel Formulations
• Quantitative Assessment of the Application and Consumption of Topical Acne Medication by Patients
• Sulfacetamide/Sulfur Combination With Sunscreen for Rosacea
Faculty/Faculty Disclosure Statement
James Q. Del Rosso, DO, FAOCD
University of Nevada
School of Medicine
Las Vegas
Received funding for clinical grants: Galderma S.A., Intendis Inc., Medicis Pharmaceutical Corporations, Stiefel Laboratories, Inc.
Consultant: Galderma, Intendis, Stiefel.
He discusses the use of metronidazole and azelaic acid as a once-a-day treatment for rosacea as opposed to twice daily.
Copyright © 2005 by International Medical News Group
A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on a faculty interview and reviews of selected posters that were presented at a medical conference held February 18-22, 2005, in New Orleans.
•Contents
•Faculty/Faculty Disclosure Statement
To view the supplement, click the image above.
Contents
• Combination Tazarotene and Clindamycin/Benzoyl Peroxide
• Use of Clindamycin 1%/Benzoyl Peroxide 5% Gel Alone and in Combination for Acne Vulgaris
• Patient Preference for Clindamycin/Benzoyl Peroxide Gel Formulations
• Quantitative Assessment of the Application and Consumption of Topical Acne Medication by Patients
• Sulfacetamide/Sulfur Combination With Sunscreen for Rosacea
Faculty/Faculty Disclosure Statement
James Q. Del Rosso, DO, FAOCD
University of Nevada
School of Medicine
Las Vegas
Received funding for clinical grants: Galderma S.A., Intendis Inc., Medicis Pharmaceutical Corporations, Stiefel Laboratories, Inc.
Consultant: Galderma, Intendis, Stiefel.
He discusses the use of metronidazole and azelaic acid as a once-a-day treatment for rosacea as opposed to twice daily.
Copyright © 2005 by International Medical News Group
A supplement to Skin & Allergy News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on a faculty interview and reviews of selected posters that were presented at a medical conference held February 18-22, 2005, in New Orleans.
•Contents
•Faculty/Faculty Disclosure Statement
To view the supplement, click the image above.
Contents
• Combination Tazarotene and Clindamycin/Benzoyl Peroxide
• Use of Clindamycin 1%/Benzoyl Peroxide 5% Gel Alone and in Combination for Acne Vulgaris
• Patient Preference for Clindamycin/Benzoyl Peroxide Gel Formulations
• Quantitative Assessment of the Application and Consumption of Topical Acne Medication by Patients
• Sulfacetamide/Sulfur Combination With Sunscreen for Rosacea
Faculty/Faculty Disclosure Statement
James Q. Del Rosso, DO, FAOCD
University of Nevada
School of Medicine
Las Vegas
Received funding for clinical grants: Galderma S.A., Intendis Inc., Medicis Pharmaceutical Corporations, Stiefel Laboratories, Inc.
Consultant: Galderma, Intendis, Stiefel.
He discusses the use of metronidazole and azelaic acid as a once-a-day treatment for rosacea as opposed to twice daily.
Copyright © 2005 by International Medical News Group
